Alzheimer’s Disease Risk Variant Rs2373115 Regulates GAB2 and NARS2 Expression in Human Brain Tissues

Guiyou Liu,Tao Wang,Rui Tian,Yang Hu,Zhifa Han,Pingping Wang,Wenyang Zhou,Peng Ren,Jian Zong,Shuilin Jin,Qinghua Jiang
DOI: https://doi.org/10.1007/s12031-018-1144-9
2018-01-01
Journal of Molecular Neuroscience
Abstract:Genetic association studies have identified significant association between the GAB2 rs2373115 variant and Alzheimer’s disease (AD). However, it is unknown whether rs2373115 affects the regulation of nearby genes. Here, we evaluate the potential effect of rs2373115 on gene expression using multiple eQTL (expression quantitative trait loci) datasets from human brain tissues from the Mayo Clinic brain expression genome-wide association study (eGWAS), the UK Brain Expression Consortium (UKBEC), the Genotype-Tissue Expression (GTEx) project, and the Brain xQTL Serve. Our findings indicate that the rs2373115 C allele is associated with increased NARS2 expression, and both reduced and increased GAB2 expression in human tissues. Using a large-scale AD case-control expression dataset, we found increased GAB2 expression and reduced NARS2 expression in AD cases compared with controls. We believe that our findings provide important information regarding the rs2373115 variant and expression of nearby genes with respect to AD risk.
What problem does this paper attempt to address?